Entry Point Capital, LLC Cerus Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
149Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$40.4 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$39.5 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$28.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$21.3 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$17.4 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $359M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...